Product Images Anoro Ellipta

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 23 images provide visual information about the product associated with Anoro Ellipta NDC 0173-0869 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Umeclidinium bromide chemical structure - anoro ellipta spl graphic 01

Umeclidinium bromide chemical structure - anoro ellipta spl graphic 01

Vilanterol trifenatate chemical structure - anoro ellipta spl graphic 02

Vilanterol trifenatate chemical structure - anoro ellipta spl graphic 02

Figure 1. Impact of Intrinsic Factors on the Pharmacokinetics (PK) of Umeclidinium (UMEC) and Vilanterol (VI) - anoro ellipta spl graphic 03

Figure 1. Impact of Intrinsic Factors on the Pharmacokinetics (PK) of Umeclidinium (UMEC) and Vilanterol (VI) - anoro ellipta spl graphic 03

Figure 2. Impact of Extrinsic Factors on the Pharmacokinetics (PK) of Umeclidinium (UMEC) and Vilanterol (VI) - anoro ellipta spl graphic 04

Figure 2. Impact of Extrinsic Factors on the Pharmacokinetics (PK) of Umeclidinium (UMEC) and Vilanterol (VI) - anoro ellipta spl graphic 04

Figure 3. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (mL) on Days 1 and 7, Day 1 - anoro ellipta spl graphic 05

Figure 3. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (mL) on Days 1 and 7, Day 1 - anoro ellipta spl graphic 05

Figure 3. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (mL) on Days 1 and 7, Day 7 - anoro ellipta spl graphic 06

Figure 3. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (mL) on Days 1 and 7, Day 7 - anoro ellipta spl graphic 06

Figure 4. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (0-24 h) (mL) on Days 1 and 28, Day 1 - anoro ellipta spl graphic 07

Figure 4. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (0-24 h) (mL) on Days 1 and 28, Day 1 - anoro ellipta spl graphic 07

Not Available.*

Figure 4. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (0-24 h) (mL) on Days 1 and 28, Day 28 - anoro ellipta spl graphic 08

Figure 4. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (0-24 h) (mL) on Days 1 and 28, Day 28 - anoro ellipta spl graphic 08

Figure 5. Least Squares (LS) Mean Change from Baseline in FEV1 (mL) over Time (0-24 h) on Days 1 and 168 (Trial 1 Subset Population), Day 1 - anoro ellipta spl graphic 09

Figure 5. Least Squares (LS) Mean Change from Baseline in FEV1 (mL) over Time (0-24 h) on Days 1 and 168 (Trial 1 Subset Population), Day 1 - anoro ellipta spl graphic 09

Figure 5. Least Squares (LS) Mean Change from Baseline in FEV1 (mL) over Time (0-24 h) on Days 1 and 168 (Trial 1 Subset Population), Day 168 - anoro ellipta spl graphic 10

Figure 5. Least Squares (LS) Mean Change from Baseline in FEV1 (mL) over Time (0-24 h) on Days 1 and 168 (Trial 1 Subset Population), Day 168 - anoro ellipta spl graphic 10

Inhaler Parts Figure - anoro ellipta spl graphic 11

Inhaler Parts Figure - anoro ellipta spl graphic 11

The text is describing two separate items, a "Tray Lid" and a "Carton". It is not possible to determine the specific details or features of these items based on this text alone.*

Figure A - anoro ellipta spl graphic 12

Figure A - anoro ellipta spl graphic 12

Figure B - anoro ellipta spl graphic 13

Figure B - anoro ellipta spl graphic 13

Figure C - anoro ellipta spl graphic 14

Figure C - anoro ellipta spl graphic 14

Figure D - anoro ellipta spl graphic 15

Figure D - anoro ellipta spl graphic 15

Figure E - anoro ellipta spl graphic 16

Figure E - anoro ellipta spl graphic 16

Figure F - anoro ellipta spl graphic 17

Figure F - anoro ellipta spl graphic 17

Figure G - anoro ellipta spl graphic 18

Figure G - anoro ellipta spl graphic 18

This text is a safety instruction advising not to block an air vent with fingers.*

Figure H - anoro ellipta spl graphic 19

Figure H - anoro ellipta spl graphic 19

Figure I - anoro ellipta spl graphic 20

Figure I - anoro ellipta spl graphic 20

Figure J - anoro ellipta spl graphic 21

Figure J - anoro ellipta spl graphic 21

Figure K - anoro ellipta spl graphic 22

Figure K - anoro ellipta spl graphic 22

Anoro Ellipta 30 dose carton - anoro ellipta spl graphic 23

Anoro Ellipta 30 dose carton - anoro ellipta spl graphic 23

ANORO Ellipta is a prescription medication that contains a combination of umeclidinium and vilanterol. It comes as an inhalation powder for oral inhalation only. Each strip contains blisters of umeclidinium or vilanterol with magnesium stearate and lactose monohydrate. The product comes with 30 doses and a total of 60 blisters. The NDC code for ANORO Ellipta is 0173-0869-10. It is important to note that it is Rx only, meaning it requires a prescription from a healthcare provider.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.